Download PDF
Fortschr Neurol Psychiatr 2024; 92(07/08): 310-326
DOI: 10.1055/a-2256-4976
Fort- und Weiterbildung

Akutbehandlung der Schizophrenie

Acute Treatment Of Schizophrenia
Aslihan Aksar
,
Alkomiet Hasan
› Further Information
Also available at
    Permissions and Reprints

Schizophrenie zählt zu den häufigsten, schwersten und kostenträchtigsten psychischen Erkrankungen bei Erwachsenen. In der Akutphase erleben die Betroffenen durch die veränderte Wahrnehmung meistens massive Ängste und einen hohen Leidensdruck. Bei starker Symptomausprägung können psychiatrische Notfälle entstehen. Eine frühestmögliche, von den Betroffenen angemessen empfundene, antipsychotische Behandlung ist für die Akutbehandlung essenziell.

Abstract

Schizophrenia is one of the most common, most severe and most costly mental illnesses in adults. In the acute phase, sufferers usually experience massive anxiety and a high level of distress due to their altered perception. If the symptoms are severe, psychiatric emergencies can arise. The earliest possible antipsychotic treatment, which is felt to be appropriate by those affected, is essential for acute treatment.

Schlüsselwörter

Schizophrenie - Akuttherapie - Antipsychotika - psychiatrischer Notfall - Wahrnehmungssörung - Affektivitätsstörung

Keywords

Schizophrenia - acute therapy - antipsychotics - psychiatrischer Notfall - psychiatric emergency - perceptual disorder - affective disorder


Publication History

Article published online:
18 July 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Gaebel W, Wölwer W. Themenheft 50 „Schizophrenie“. Berlin: Robert Koch-Institut; 2010
    Search in Google Scholar
  • 2 Holzbach R. Die Akutbehandlung der Schizophrenie. psychoneuro 2003; 29: 522-526
    Thieme ConnectPubMedSearch in Google Scholar
  • 3 Hasan A, Falkai P, Lehmann I. et al. Schizophrenia. Dtsch Ärztebl Int 2020; 117: 412-419
    CrossrefPubMedSearch in Google Scholar
  • 4 DGPPN e. V. S3-Leitlinie Schizophrenie. Kurzfassung 2019. Version 1.0, zuletzt geändert am 15.März 2019. https://www.awmf.org/leitlinien/detail/ll/038–009.html
    PubMed
  • 5 Thibaut F. Acute treatment of schizophrenia: introduction to the Word Federation of Societies of Biological Psychiatry guidelines. Psychiatr Danub 2014; 26: 2-11
    PubMedSearch in Google Scholar
  • 6 Huhn M, Schneider-Thoma J, Leucht S. Langzeittherapie der Schizophrenie. PSYCH up2date 2022; 16: 493-511
    Thieme ConnectPubMedSearch in Google Scholar
  • 7 Zhu Y, Li C, Huhn M. et al. How well do patients with a first episode of schizophrenia respond to antipsychotics: A systematic review and meta-analysis. European Neuropsychopharmacology 2017; 27: 835-844
    CrossrefPubMedSearch in Google Scholar
  • 8 Leucht S, Leucht C, Huhn M. et al. Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors. Am J Psychiatry 2017; 174: 927-942
    CrossrefPubMedSearch in Google Scholar
  • 9 Oeser C, Steinberg H. Die Einführung der Antipsychotika an der Neurologisch-Psychiatrischen Klinik der Universität Leipzig und ihre Auswirkungen auf andere Therapieformen sowie auf die Verweildauern und Verlegungen. Nervenarzt 2021; 92: 69-80
    CrossrefPubMedSearch in Google Scholar
  • 10 Carlsson A, Lindqvist M. Effect of Chlorpromazine or Haloperidol on Formation of 3-Methoxytyramine and Normetanephrine in Mouse Brain. Acta Pharmacol Toxicol (Copenh) 1963; 20: 140-144
    CrossrefPubMedSearch in Google Scholar
  • 11 Farah A. Atypicality of Atypical Antipsychotics. Prim Care Companion J Clin Psychiatry 2005; 7: 268-274
    CrossrefPubMedSearch in Google Scholar
  • 12 Hasan A, Leucht S. Erkennen und behandeln von Antipsychotika-Nebenwirkungen. InFo Neurologie 2022; 24: 43-55
    CrossrefPubMedSearch in Google Scholar
  • 13 Correll CU, Martin A, Patel C. et al. Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. Schizophr 2022; 8: 5
    CrossrefPubMedSearch in Google Scholar
  • 14 Huhn M, Nikolakopoulou A, Schneider-Thoma J. et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394: 939-951
    CrossrefPubMedSearch in Google Scholar
  • 15 Leucht S, Schneider-Thoma J, Burschinski A. et al. Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network metaanalysis. World Psychiatry 2023; 22: 315-324
    CrossrefPubMedSearch in Google Scholar
  • 16 Zhang JP, Gallego JA, Robinson DG. et al. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol 2013; 16: 1205-1218
    CrossrefPubMedSearch in Google Scholar
  • 17 Leucht S, Crippa A, Siafis S. et al. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. Am J Psychiatry 2020; 177: 342-353
    CrossrefPubMedSearch in Google Scholar
  • 18 Gardner DM, Murphy AL, O’Donnell H. et al. International Consensus Study of Antipsychotic Dosing. Am J Psychiatry 2010; 167: 686-693
    CrossrefPubMedSearch in Google Scholar
  • 19 Takeuchi H, MacKenzie NE, Samaroo D. et al. Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis. Schizophr Bull 2020; 46: 1439-1458
    CrossrefPubMedSearch in Google Scholar
  • 20 Braude WM, Barnes TRE, Gore SM. Clinical Characteristics of Akathisia: A Systematic Investigation of Acute Psychiatric Inpatient Admissions. Br J Psychiatry 1983; 143: 139-150
    CrossrefPubMedSearch in Google Scholar
  • 21 Simon LV, Hashmi MF, Callahan AL. Neuroleptic Malignant Syndrome. 2023: Zugriff am 27. Juli 2023 https://www.ncbi.nlm.nih.gov/books/NBK482282/
    PubMed
  • 22 Müller MJ, Benkert O. Antipsychotika. In: Benkert O, Hippius H (eds.) Kompendium der Psychiatrischen Pharmakotherapie. Berlin: Springer; 2017: 269-488
    CrossrefSearch in Google Scholar
  • 23 Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 1987; 13: 261-276
    CrossrefPubMedSearch in Google Scholar
  • 24 Kinon B, Chen L, Aschersvanum H. et al. Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia. Schizophr Res 2008; 102: 230-240
    CrossrefPubMedSearch in Google Scholar
  • 25 Demjaha A, Lappin JM, Stahl D. et al. Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors. Psychol Med 2017; 47: 1981-1989
    CrossrefPubMedSearch in Google Scholar
  • 26 Siskind D, Orr S, Sinha S. et al. Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis. Br J Psychiatry 2022; 220: 115-120
    CrossrefPubMedSearch in Google Scholar
  • 27 Bäuml J, Pitschel-Walz G, Bechdolf A. et al. Psychoedukation bei schizophrenen Erkrankungen. Konsensuspapier der Arbeitsgruppe „Psychoeduaktion bei schizophrenen Erkrankungen“. Stuttgart: Schattauer;; 2008
    Search in Google Scholar
  • 28 Mavandadi V, Bieling PJ, Madsen V. Effective ingredients of verbal de-escalation: validating an English modified version of the ‘De-Escalating Aggressive Behaviour Scale’. J Psychiatr Ment Health Nurs 2016; 23: 357-368
    CrossrefPubMedSearch in Google Scholar
  • 29 Möller HJ, Laux G, Deister A. Duale Reihe Psychiatrie, Psychosomatik und Psychotherapie. Stuttgart: Thieme; 2022
    Search in Google Scholar